These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16625050)

  • 1. Determination of antifungal activities in serum samples from mice treated with different antifungal drugs allows detection of an active metabolite of itraconazole.
    Maki K; Watabe E; Iguchi Y; Nakamura H; Tomishima M; Ohki H; Yamada A; Matsumoto S; Ikeda F; Tawara S; Mutoh S
    Microbiol Immunol; 2006; 50(4):281-92. PubMed ID: 16625050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.
    Maki K; Holmes AR; Watabe E; Iguchi Y; Matsumoto S; Ikeda F; Tawara S; Mutoh S
    Microbiol Immunol; 2007; 51(11):1053-9. PubMed ID: 18037782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective concentration-based serum pharmacodynamics for antifungal azoles in a murine model of disseminated Candida albicans infection.
    Maki K; Kaneko S
    Eur J Drug Metab Pharmacokinet; 2013 Dec; 38(4):261-8. PubMed ID: 23539473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
    Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
    J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
    Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
    J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
    Yotsuji A; Shimizu K; Araki H; Fujimaki K; Nishida N; Hori R; Annen N; Yamamoto S; Hayakawa H; Imaizumi H; Watanbe Y; Narita H
    Antimicrob Agents Chemother; 1997 Jan; 41(1):30-4. PubMed ID: 8980750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
    J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
    Denning DW; Radford SA; Oakley KL; Hall L; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay.
    Mikami Y; Sakamoto T; Yazawa K; Gonoi T; Ueno Y; Hasegawa S
    Mycoses; 1994; 37(1-2):27-33. PubMed ID: 7935588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.
    Denardi LB; Keller JT; de Azevedo MI; Oliveira V; Piasentin FB; Severo CB; Santurio JM; Alves SH
    Mycopathologia; 2018 Apr; 183(2):359-370. PubMed ID: 28994001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
    Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
    Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
    Heller I; Leitner S; Dierich MP; Lass-Flörl C
    Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Wetter TJ; Hazen KC; Cutler JE
    Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
    Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP
    J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.
    Jahn B; Martin E; Stueben A; Bhakdi S
    J Clin Microbiol; 1995 Mar; 33(3):661-7. PubMed ID: 7751374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.